Anondita Medicare Limited vs Nestle India Limited

A side-by-side comparison of Anondita Medicare Limited (ANONDITA) and Nestle India Limited (NESTLEIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Anondita Medicare Limited leads ANONDITA vs NESTLEIND on 7 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability31
  • Growth· not comparable—
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ANONDITA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

49.69
P/E ratio
68.85
9.76
P/B ratio
52.54
0.00%
Dividend yield
0.92%
₹20.77
EPS
₹18.38

Profitability

ANONDITA takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

26.54%
Return on equity
0.00%
30.97%
Return on capital
69.72%
36.87%
EBITDA margin
22.92%
24.96%
Net margin
15.11%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

—
Revenue CAGR (3Y) even
6.58%
—
Profit CAGR (3Y) even
5.28%

Size & financial health

NESTLEIND takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2,041 Cr
Market cap
₹2.44L Cr
₹137 Cr
Revenue
₹23,155 Cr
₹34 Cr
Net profit
₹3,499 Cr
0.26
Debt / equity
0.31
Anondita Medicare Limited
  • + []
  • − ["Stock is trading at 15.79 times its book value"]
Nestle India Limited
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 94.0%", "Company has been maintaining a healthy dividend payout of 77.2%"]
  • − ["Stock is trading at 47.32 times its book value"]
Anondita Medicare Limited full analysis Nestle India Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.